Hematology TimesFDA grants priority review for midostaurinNovember 15, 2016CythemiasLeukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsInvestigational AML drugs boosted remission ratesNovember 9, 2016AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCombating drug resistance in FLT3-mutated AMLNovember 6, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesTeam targets fructose to treat AMLNovember 4, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesTargeting CD98 to treat AMLNovember 3, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesTeam maps genomic landscape of CBF-AMLNovember 1, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsAndrogen improved survival in elderly AML patientsOctober 26, 2016AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCompound could treat a range of blood cancersOctober 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin Lymphoma
Hematology TimesCombo produces CR/CRis in FLT3-ITD AMLOctober 20, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesWork reveals potential therapeutic targets in AMLOctober 19, 2016Leukemia, Myelodysplasia, TransplantationThrombosisAML
Hematology TimesProteins may be therapeutic targets for AML subtypeOctober 17, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesCombo could treat AML, other cancersOctober 14, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology Times‘Practice-changing’ treatments emerging in AMLOctober 6, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesInflammation may predict transformation to AMLOctober 5, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesHow anti-CD44 antibodies fight AMLSeptember 26, 2016Leukemia, Myelodysplasia, TransplantationAML
